The relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis
Objectives To analyse the relationship between the type I interferon (IFN) signature and the response to rituximab in rheumatoid arthritis (RA) patients. In peripheral blood mononuclear cells from baseline the presence of an IFN signature was analysed by measuring the expression levels of three IFN...
Gespeichert in:
| Veröffentlicht in: | Annals of the rheumatic diseases 2010-03, Vol.69 (Suppl 2), p.A14-A15 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | A15 |
|---|---|
| container_issue | Suppl 2 |
| container_start_page | A14 |
| container_title | Annals of the rheumatic diseases |
| container_volume | 69 |
| creator | Thurlings, R M Boumans, M Tekstra, J Vos, K van Westing, D M van Baarsen, L G Bos, C Kirou, K A Gerlag, D M Crow, M K Verweij, C L Tak, P P |
| description | Objectives To analyse the relationship between the type I interferon (IFN) signature and the response to rituximab in rheumatoid arthritis (RA) patients. In peripheral blood mononuclear cells from baseline the presence of an IFN signature was analysed by measuring the expression levels of three IFN response genes by quantitative PCR. |
| doi_str_mv | 10.1136/ard.2010.129585k |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1777859368</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4008500521</sourcerecordid><originalsourceid>FETCH-LOGICAL-b185k-8701f98d66407ec24995a86d9b99122105b404ad9adc8db8388ae7f406f4a86d3</originalsourceid><addsrcrecordid>eNqFkEtLAzEUhYMoWKt7lwGXMjWZRx5LKVoLRVGqiJuQ6dxx0sfMmGSw_fdmbHHr6nI53zn3chC6pGREacJutC1GMem3WGYiWx2hAU2ZiGLCyDEaEEKSKJWMn6Iz55ZhJYKKAarnFWALa-1NU7vKtDgH_w1QYx8Ev2sBT7GpPdgSbFNjZz5r7TsLWNfFL2PBtcEa4AZb47ut2eg8WLCtoNto35gCa-uroBl3jk5KvXZwcZhD9Hp_Nx8_RLOnyXR8O4tyGn6PBCe0lKJgLCUcFnEqZaYFK2QuJY1jSrI8JakupC4WoshFIoQGXqaElWnPJUN0tc9tbfPVgfNq2XS2DicV5ZyLTCZMBIrsqYVtnLNQqtaG7-1OUaL6VlVoVfWtqkOrwRLtLcZ52P7x2q4U4wnP1OPbWH2837MJe35RceCv93y-Wf6f_gMerIkz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777859368</pqid></control><display><type>article</type><title>The relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis</title><source>BMJ Journals - NESLi2</source><creator>Thurlings, R M ; Boumans, M ; Tekstra, J ; Vos, K ; van Westing, D M ; van Baarsen, L G ; Bos, C ; Kirou, K A ; Gerlag, D M ; Crow, M K ; Verweij, C L ; Tak, P P</creator><creatorcontrib>Thurlings, R M ; Boumans, M ; Tekstra, J ; Vos, K ; van Westing, D M ; van Baarsen, L G ; Bos, C ; Kirou, K A ; Gerlag, D M ; Crow, M K ; Verweij, C L ; Tak, P P</creatorcontrib><description>Objectives To analyse the relationship between the type I interferon (IFN) signature and the response to rituximab in rheumatoid arthritis (RA) patients. In peripheral blood mononuclear cells from baseline the presence of an IFN signature was analysed by measuring the expression levels of three IFN response genes by quantitative PCR.</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/ard.2010.129585k</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><subject>Biological activity ; Funding ; Rheumatoid arthritis</subject><ispartof>Annals of the rheumatic diseases, 2010-03, Vol.69 (Suppl 2), p.A14-A15</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2010 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/69/Suppl_2/A14.4.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/69/Suppl_2/A14.4.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,3194,23570,27923,27924,77371,77402</link.rule.ids></links><search><creatorcontrib>Thurlings, R M</creatorcontrib><creatorcontrib>Boumans, M</creatorcontrib><creatorcontrib>Tekstra, J</creatorcontrib><creatorcontrib>Vos, K</creatorcontrib><creatorcontrib>van Westing, D M</creatorcontrib><creatorcontrib>van Baarsen, L G</creatorcontrib><creatorcontrib>Bos, C</creatorcontrib><creatorcontrib>Kirou, K A</creatorcontrib><creatorcontrib>Gerlag, D M</creatorcontrib><creatorcontrib>Crow, M K</creatorcontrib><creatorcontrib>Verweij, C L</creatorcontrib><creatorcontrib>Tak, P P</creatorcontrib><title>The relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis</title><title>Annals of the rheumatic diseases</title><addtitle>Ann Rheum Dis</addtitle><description>Objectives To analyse the relationship between the type I interferon (IFN) signature and the response to rituximab in rheumatoid arthritis (RA) patients. In peripheral blood mononuclear cells from baseline the presence of an IFN signature was analysed by measuring the expression levels of three IFN response genes by quantitative PCR.</description><subject>Biological activity</subject><subject>Funding</subject><subject>Rheumatoid arthritis</subject><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkEtLAzEUhYMoWKt7lwGXMjWZRx5LKVoLRVGqiJuQ6dxx0sfMmGSw_fdmbHHr6nI53zn3chC6pGREacJutC1GMem3WGYiWx2hAU2ZiGLCyDEaEEKSKJWMn6Iz55ZhJYKKAarnFWALa-1NU7vKtDgH_w1QYx8Ev2sBT7GpPdgSbFNjZz5r7TsLWNfFL2PBtcEa4AZb47ut2eg8WLCtoNto35gCa-uroBl3jk5KvXZwcZhD9Hp_Nx8_RLOnyXR8O4tyGn6PBCe0lKJgLCUcFnEqZaYFK2QuJY1jSrI8JakupC4WoshFIoQGXqaElWnPJUN0tc9tbfPVgfNq2XS2DicV5ZyLTCZMBIrsqYVtnLNQqtaG7-1OUaL6VlVoVfWtqkOrwRLtLcZ52P7x2q4U4wnP1OPbWH2837MJe35RceCv93y-Wf6f_gMerIkz</recordid><startdate>201003</startdate><enddate>201003</enddate><creator>Thurlings, R M</creator><creator>Boumans, M</creator><creator>Tekstra, J</creator><creator>Vos, K</creator><creator>van Westing, D M</creator><creator>van Baarsen, L G</creator><creator>Bos, C</creator><creator>Kirou, K A</creator><creator>Gerlag, D M</creator><creator>Crow, M K</creator><creator>Verweij, C L</creator><creator>Tak, P P</creator><general>BMJ Publishing Group Ltd and European League Against Rheumatism</general><general>Elsevier Limited</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>201003</creationdate><title>The relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis</title><author>Thurlings, R M ; Boumans, M ; Tekstra, J ; Vos, K ; van Westing, D M ; van Baarsen, L G ; Bos, C ; Kirou, K A ; Gerlag, D M ; Crow, M K ; Verweij, C L ; Tak, P P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b185k-8701f98d66407ec24995a86d9b99122105b404ad9adc8db8388ae7f406f4a86d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Biological activity</topic><topic>Funding</topic><topic>Rheumatoid arthritis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thurlings, R M</creatorcontrib><creatorcontrib>Boumans, M</creatorcontrib><creatorcontrib>Tekstra, J</creatorcontrib><creatorcontrib>Vos, K</creatorcontrib><creatorcontrib>van Westing, D M</creatorcontrib><creatorcontrib>van Baarsen, L G</creatorcontrib><creatorcontrib>Bos, C</creatorcontrib><creatorcontrib>Kirou, K A</creatorcontrib><creatorcontrib>Gerlag, D M</creatorcontrib><creatorcontrib>Crow, M K</creatorcontrib><creatorcontrib>Verweij, C L</creatorcontrib><creatorcontrib>Tak, P P</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thurlings, R M</au><au>Boumans, M</au><au>Tekstra, J</au><au>Vos, K</au><au>van Westing, D M</au><au>van Baarsen, L G</au><au>Bos, C</au><au>Kirou, K A</au><au>Gerlag, D M</au><au>Crow, M K</au><au>Verweij, C L</au><au>Tak, P P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis</atitle><jtitle>Annals of the rheumatic diseases</jtitle><addtitle>Ann Rheum Dis</addtitle><date>2010-03</date><risdate>2010</risdate><volume>69</volume><issue>Suppl 2</issue><spage>A14</spage><epage>A15</epage><pages>A14-A15</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>Objectives To analyse the relationship between the type I interferon (IFN) signature and the response to rituximab in rheumatoid arthritis (RA) patients. In peripheral blood mononuclear cells from baseline the presence of an IFN signature was analysed by measuring the expression levels of three IFN response genes by quantitative PCR.</abstract><cop>Kidlington</cop><pub>BMJ Publishing Group Ltd and European League Against Rheumatism</pub><doi>10.1136/ard.2010.129585k</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0003-4967 |
| ispartof | Annals of the rheumatic diseases, 2010-03, Vol.69 (Suppl 2), p.A14-A15 |
| issn | 0003-4967 1468-2060 |
| language | eng |
| recordid | cdi_proquest_journals_1777859368 |
| source | BMJ Journals - NESLi2 |
| subjects | Biological activity Funding Rheumatoid arthritis |
| title | The relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T04%3A02%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20relationship%20between%20the%20type%20I%20interferon%20signature%20and%20the%20response%20to%20rituximab%20in%20rheumatoid%20arthritis&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Thurlings,%20R%20M&rft.date=2010-03&rft.volume=69&rft.issue=Suppl%202&rft.spage=A14&rft.epage=A15&rft.pages=A14-A15&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/ard.2010.129585k&rft_dat=%3Cproquest_cross%3E4008500521%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777859368&rft_id=info:pmid/&rfr_iscdi=true |